Background: Renal replacement is managed by renal specialists and is well documented in national registries. In contrast, nation-wide data on acute kidney injury (AKI) are difficult to capture as it presents in many different ways to all acute hospitals. This paucity impacts on the coordination of appropriate services. Aims: We have set out to use all the information submitted by all hospitals in England to identify emergency patients in whom AKI was a major contributor to their hospital stay. We then examined workload in relation to specialist provision and outcomes of care. Design and Methods: All English hospitals submit a sequential list of International Statistical
Introduction
Dialysis for established renal failure is a medical success story that has led to specialist renal services being developed in a limited number of centres. Dialysis outcomes are well documented. 1 In contrast, in England, acute kidney injury (AKI) presents to every district hospital and is usually managed by non-renal specialists, 2,3 because many hospitals have no renal physicians on their staff. Whereas there are some indications that mortality rates are improving, 4 AKI has a high mortality 5 and the incidence is increasing, 5, 6 but there are few data as to how it is managed or by whom. AKI is precipitated by a variety of renal and nonrenal disorders, and its outcomes range from complete recovery of kidney function to established renal failure (needing dialysis) or death. Previous studies have focused on AKI in specific clinical settings, 7 in relation to certain procedures 8 or, less frequently, have been population based. 5, 9 The variable presentation means there is little information about the national picture that could help develop appropriate services.
The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) studied patients who had died of AKI in the first 3 months of 2007. 10 It documented poor care in up to 50% of the patients, delays in diagnosis and poor management of complications in 22%. The report noted that only 32% of the patients were referred to a nephrologist and 20% of those who were not referred should have been. Coming from a different angle, we had commenced work in early 2008 using all the information in the Hospital Episode Statistics (HES) diagnostic coding to identify patients in whom AKI was a major contributor to their in-patient stay and then to examine the workload in relation to specialist provision and the outcomes of care.
Methods Case selection of AKI
All hospitals submit a sequential list of International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD 10) codes to describe the diagnosis of each admission. AKI presents in many different ways and the renal diagnostic code is often not the first in the list-it was rare after position 7 and thus we restricted analysis to the first 7 codes per patient. We developed a list of codes directly descriptive of AKI (Appendix Tables  A1 and A2 ) and applied it to all the ICD diagnosis codes for each patient and established three categories of disease:
definite AKI when one of the listed codes appeared in the first position; probable AKI when one of the listed codes was in any of positions 2-7 with specific associated codes (from an additional list) in the earlier positions, suggesting that AKI was a major contributor to the episode; and possible AKI when there was an AKI code present but where it may have been a co-morbidity with another disorder as the primary problem.
We have included Definite and Probable groups as indicating AKI.
Renal transplant rejection was not included in the AKI codes, but chronic kidney disease (CKD) and renal transplant recipient status were not excluded from the co-morbidities.
The algorithm was applied to all adult emergency medical admissions recorded in HES for England for 2006-07 and 2007-08 with the linked mortality data from the Office of National Statistics (the death register). Day cases and elective admissions were excluded. We studied the whole period of the individual's in-patient stay and used the discharge diagnoses to capture both, those who presented to hospital with AKI and those who developed AKI during their hospital stay.
Defining renal services
We identified renal specialists from a combination of the Renal Association and electronic staff records, augmented by email and telephone requests to individual hospitals. These contacts were also used to confirm the types of renal service. All English hospitals are managed by trusts, who may administer one or more hospitals serving a catchment population. Each trust was classified as having a transplant unit (T), an on-site renal department (O) or visiting renal input only (V).
Analysis
All analyses were performed using Statistical Package for the Social Sciences (v16) and comparisons were performed with unpaired t-tests or chisquared tests as appropriate. Mortality results (using the Office of National Statistics death data linked to the HES data) were corrected for a variety of known confounders for a 30-day period. Age is non-linearly related to mortality, so corrections were performed by comparing each 5-year-age band in each trust with the national mortality for that age band with lookup tables. Corrections were also applied for the index of multiple deprivations (a standard HES variable) and for a co-morbidity variable derived by excluding renal diagnoses from the Charlson index.
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Mortality rates were plotted on funnel charts with 99% confidence limits. We also compared the trusts in the highest and lowest mortality quartiles to explore for systematic variations in coding or other factors that might explain the variability observed.
Finally, a multiple logistic regression was used to compare mortality risk between the different types of renal services using age, co-morbidity, deprivation and mortality in patients without AKI as dependent variables. The data were re-run (i) excluding patients transferred between units and (ii) for patients only with an ICD 10 code of N179 that carries the descriptor of 'acute renal failure unspecified'.
Initial analyses were performed on each year of data separately, but because the years were entirely consistent, a combined analysis is presented here.
Face validity
A steering group that included representation from the Renal Association (UK), the National Clinical Director for Kidney Care, British Renal Society, UK Renal Registry, National Kidney Federation, NHS Information Centre and public health experts, oversaw the methodology and remained involved in the analysis, feedback and review process. Procedures were piloted and refined on 4 renal networks consisting of 16 trusts that had representatives in the steering group.
In addition, all consultant nephrologists in England were emailed data comparing their respective units with national means for the three categories of trusts. A feedback questionnaire asked about (i) accuracy of our description of their trust service, (ii) the relevance of the data to their trust and (iii) whether there were issues that appeared wrong. If there was no nephrologist, Medical Directors were sent their institution's data and a different questionnaire. This feedback was used to further interrogate the data and correct the discrepancies.
Role of the funding source
The Information Centre (IC) of the National Health Service part funded Elizabeth Thompson's work on this project. The IC also facilitated meetings of the steering group and provided the raw data from HES.
Results

Renal services
Mapping of renal networks, their hubs, spokes and types of renal cover showed that there were 21 hospital trusts that performed renal transplantation (T), 47 that had on-site renal departments (O) and 82 trusts (55%) that had visiting renal input but no specialists on their staff (V).
Coding
More renal disease was recorded in 2007-08 and this was associated with an increase in the number of codes recorded per patient (5.9 vs. 5.7 in 2006-07). However, the proportion of patients admitted with AKI was the same and the changes were similar in the T, O and V trusts.
AKI admissions
There were 4 637 488 emergency medical admissions to 150 English trusts, of which 61 739 (1.34%, range 0.48-2.56) had AKI. Of these, 57.3% were selected using the first diagnostic position alone and 42.7% with the additional analysis of Positions 2-7. Table 1 shows that the trusts without renal specialists were smaller, but that the proportion of AKI cases within the total emergency load was very similar.
The types of cases admitted were similar in the three hospital types. The top five codes in the first diagnostic position were identical in each group (Appendix Table A3 ). Ethnicity, co-morbidity (Appendix Table A4 ) and the Index of Multiple Deprivation were also similar, but there were significant differences in age in the three hospital groups with a higher proportion of older patients in the small hospitals without specialists. A minority of patients were discharged from the care of a renal specialist regardless of the size or type of hospital.
Outcomes
AKI had a high all-cause mortality-median 30.0% within admission and 30.0% within 30 days. There was no difference in mortality between Caucasian and non-White ethnic groups. Hospitals without specialist renal services had a higher mortality (P < 0.001) for AKI patients, but their patients were older. Controlling for age, deprivation and co-morbidity reduced the absolute differences, but they remained significant (Table 2) . Patients who also had CKD or a renal transplant had lower mortality [odds ratio (OR) 0.62, confidence interval (CI) 0.60-0.64 for CKD and OR 0.40, 95% CI 0.26-0.61 for renal transplant] than patients who developed AKI de novo. But regardless of baseline renal dysfunction, the differences in mortality between the different types of renal services remained significant. Charting results on a funnel plot showed that mortality was not related to hospital size, but 17 trusts with higher and 19 with lower mortality were outside the 3 standard deviation lines ( Figure 1 ). Where renal specialists were on-site, significantly more patients with AKI received renal replacement therapy.
Inter hospital transfers
Some patients presenting as emergencies to small hospitals were transferred to specialist units. Such transfers led to 13.7% of admissions to transplanting and 5.7% to on-site renal trusts. These transfer patients were younger than patients presenting directly to the Emergency Departments (mean age 64 vs. 73 years), suggesting possible selection bias leading to better results. However, when the transferred patients were compared with those presenting directly to the hospital trusts with on-site renal services, there were no significant differences in the outcomes adjusted for age, deprivation and co-morbidity. Such patients, therefore, had mortality rates similar to the receiving hospital rather than the hospital they were transferred from. Repeating the comparisons between units with these patients excluded did not remove the mortality differences between types of units.
Consultant provision
One Strategic Health Authority, London stood out from the rest. Patients admitted to London trusts were of similar age, case mix and co-morbidity as the rest of the country, but had a significantly lower mortality (Table 3) . This region contained 30% of the country's transplant trusts and had 86% more nephrologists per unit population.
Access to specialist care
A multiple logistic regression confirmed that age, co-morbidity and hospital type were strong predictors of 30-day mortality and that adding deprivation quintile or ethnicity did not improve the prediction equation. The increased OR for mortality in trusts with only a visiting service (1.32) mirror the results obtained above, but the O trusts also had a higher rate mortality (OR 1.11) than the T trusts.
To explore this further, the data for all emergency medical admissions (but excluding the AKI cohort) to these hospitals were explored with the same adjustments for age, deprivation and co-morbidity. Median 30-day mortality was 8.3% (trust range Different from T units at P < 0.01.
5.5-11.5) and regression analysis showed that both O trusts (OR 1.12, range 1.10-1.14) and V trusts (OR 1.16, range 1.14-1.18) had an increased mortality vs. the T trusts. To control for this non-renal hospitalrelated pattern, trusts were divided into five mortality quintiles and that new variable was added to the regression for the AKI patients. The result is that the AKI mortality difference between the transplant and on-site renal service hospitals disappears, but there remain significant differences between V trusts and those with on-site renal services. The OR between visiting hospitals and transplant units was 1.17 (P < 0.001) ( Table 4) . If all hospitals had the same AKI mortality as the median of T trusts, it was projected that 2811 deaths could have been prevented over the 2-year period. Of these excess deaths in the non-transplant trusts, estimations based on OR are that about half were due to the non-renal differences and half due to the renal specific factors. This regression model was re-run adding in variables to challenge the primary conclusion. This did not improve the overall fit statistically, but did show that lower mortality was associated with being discharged from care of a renal physician, OR 0.42 (95% CI 0.39-0.45). Repeating the regression by first excluding all inter-hospital transfer patients and then only including the 26 723 patients with acute renal failure code N179 as the first diagnosis yielded similar conclusions. 
External validity
Internal consistency
Finally, we extended this multiple logistic regression analysis to the 'Possible AKI' group who had been excluded in the above analysis. This group, in which AKI was coded but thought subsidiary to another condition, comprised a further 1.5% of all emergency admissions. A similar pattern of lower mortality in trusts with renal specialists was apparent before and after control for age, deprivation and other co-morbidities but with a borderline statistical confidence (P < 0.05).
Discussion
AKI has a high mortality and our primary conclusion suggests that mortality is lower when there is more expertise around-supporting the conclusions of the NCEPOD audit. 10 It suggests that the country should re-think the way it provides for AKI.
Whereas there are strengths in examining all cases admitted across a nation, there are also some assumptions that warrant discussion.
Case selection and data issues
Our discussions with current specialists simplified renal disease to the two headings AKI and CKD. The definition of AKI is not straightforward because it can be caused by many pathological processes and the AKI codes can appear late in the diagnostic list. Also, ICD codes for AKI are known to be specific but not very sensitive. 12 It was important to examine all cases that clinicians would consider had AKI and that meant creating algorithms that are based on the way AKI behaves clinically. This is different from the Health Resource Groups logic based on resource use.
We think that this more clinical approach is justified because it provides a more typical picture of the AKI workload in each trust and detects a high mortality group with remediable disease.
Variability in coding in different trusts remains a concern, 12 but our comparisons of coding across the three types of hospital trusts were consistent. The number of diagnostic codes used ('coding depth'), the frequency of the top five codes used and the reported co-morbidity and deprivation indices were all similar.
Our processes and outcomes have been shared with clinicians across the country and have been supported. The algorithms increase the number of AKI cases by 75% more than if we had only used the first coded diagnosis, and doubled the number of recorded deaths. To ensure we have not biased the conclusions, the analyses were repeated first limiting cases to the strictest possible definition, i.e. those with acute renal failure (ICD code N179), in the first position and second, extending the study group to include the cases of possible AKI. The same patterns were seen in both analyses. Therefore, even if the inclusion thresholds are refined in future, it is unlikely to alter the conclusion.
Mortality
AKI comprises 1.3% of all emergency admissions, which is comparable with the proportion of acute diabetes admissions. 13 This proportion was similar across the types of acute trusts and had a similar diagnostic mix. This is perhaps unsurprising as, in England, the choice of hospital is determined more by local geography and closeness to the patient's home than the service available. 14, 15 The 30% 30-day mortality for AKI is more than twice as high as for acute myocardial infarction 16 or chronic obstructive pulmonary disease (COPD). 17 We used 30-day mortality rather than in-patient mortality as it is independent of length of stay. There is no consensus on the relative value of process measures vs. outcome measures in assessment of the quality of care. 18 All agree that unadjusted mortality rates are, on their own, insufficient, but that standardized mortality rates can be used to identify 'outliers' worthy of further investigation.
There were age differences caused in part by emergency transfer of significant number of younger patients to larger trusts. To avoid unwarranted assumptions for linear relationships, we controlled the mortality analysis within each 5-year group compared with the national mean, and also controlled for deprivation and co-morbidity. The data allow us to be reasonably sure that the differences are not due to systematic coding variability or due to a different mix of subdiagnoses. It is reassuring that the multiple logistic regressions achieved a similar result.
The logistic regression OR suggests a >30% higher mortality from AKI in the V trusts, but it is not only a renal problem. We were surprised that although these hospital groupings were chosen according to renal provision, there was a significant mortality difference for all other medical emergency admissions. Variations in mortality rates between trusts are well described, 19 but it is not clear why it should be apparent in these trust groupings. This 'non-renal effect' would seem to explain the difference between T and O trusts (who both had renal physicians on the staff), but there was still a significantly higher mortality from AKI in the V trusts with no permanent renal specialists. Thus, the higher mortality in these trusts had at least two different components-one that appears to be generic to the trust and one that appears to be primarily renal. But, taken together, the implication is that there were more than 2800 patients who died of a condition that could often be treated.
Other considerations
The outcome difference between hospital types for 'possible AKI' patients in whom we had considered AKI to be only a co-morbidity strengthens the conclusions but raises the question of whether our inclusion criteria were too cautious. The association of mild AKI with mortality has been noted before 20 and our findings question the level of AKI at which referral will prove beneficial.
Patients who had a renal transplant or pre-existing CKD had a lower 30-day mortality than patients who developed AKI de novo. Other investigators have noted findings similar to ours. 2, 4 Increased vigilance, earlier detection and greater involvement of nephrologists remain possible explanations. Interestingly, Ali et al.'s 5 study from Scotland showed that CKD patients who developed AKI were more likely to have renal imaging undertaken and to be under the care of a nephrologist. We believe that this specialist care contributed to the authors' findings that there were no significant differences in in-hospital or 90-day mortality. In addition, despite being more elderly, these patients had a shorter length of hospital stay. The authors also found that patients who had AKI on CKD had a significantly higher 6-month mortality. It is likely that in those who survive the initial insult, poorer residual renal function 21 takes time to affect mortality.
Only a small fraction of the AKI cases described here will be included in the UK Renal Registry database as most will not require long-term renal replacement therapy. Across the world, registry reports have helped to plan chronic dialysis services. Our study brings the national picture of AKI in England into focus with the potential for similar benefits in a different group of renal patients. These benefits can be replicated by similar population-wide studies on AKI in different countries. Besides, if better care reduces mortality, it may also reduce the proportion going on to develop CKD with all of its impact on morbidity and mortality.
Types of renal service
It is understandable that the creation of specialist renal replacement units focused on renal medicine in a few centres. Although the number of centres has increased, most acute hospitals in England have no renal specialists on their staff. These, mostly smaller, trusts depend on variable arrangements with visiting specialists.
Hospital triage systems for emergency patients vary. National audits such as the Sentinel Audit of Stroke 22 and the National COPD Resource and Outcomes Project 23 have confirmed that a well organized specialized service is associated with better patient process and outcome of care. But if there is no renal physician on the staff, there is no one to triage patients to and no one to lead the organization of renal care. NCEPOD found that on-site nephrologists were present in only 46% of acute hospitals, although only 6% of the remainder did not have access to an on-call renal service. Nephrologists provided cover from a different city to 39% of hospitals that had access to an on-call service. Other facets of a renal support service were absent in 70% of hospitals indicating that besides a nephrologist's direct contribution to a patient's care, the team that is usually set up by a nephrologist impacts on any acute service. Besides these factors, the input to juniors, to hospital fluid balance policies or to educational meetings will be impaired. Advice from a visiting renal specialist once or twice per week is unlikely to make up for this or to achieve the level of organization required. Thus, we noted that only a minority of patients received dialysis in the index admission and only when there were specialists on-site. But even in hospitals with renal specialists, only one-third of AKI patients were discharged from or died under their care. Such patients did have a better outcome despite an expectation that the more serious cases would gravitate to the specialist. Similarly, the NCEPOD audit showed that only 31% of patients who died of AKI were referred to a nephrologist, and 21% of these referrals were made later than they should have been. More striking was their finding that 20% of patients who should have been referred were not. These observations also parallel that of earlier studies 15 and imply that the lack of specialist input was one of the factors in poor care delivery.
That London SHA should be different was unexpected. It is compatible, however, with the hypothesis that having more input from specialists within the hospital is associated with better outcomes.
Regardless of the details, AKI-associated mortality remains high and the lack of an on-site renal service does affect outcomes. Using different methods to calculate the number of lives that could have been saved if all acute hospitals improved their AKI mortality rates to that of T trusts, we are left with figures of 1406 per year, half of which could be attributed to the lack of specialist care. We were unable to identify any other national study that looked at AKI mortality and service provision. The closest was an American study 24 that used the nation-wide in-patient sample (NIS) from 20% of US hospitals. The study period was from 2002 to 2006 and compared weekend vs. weekday admissions (963 730 AKI admissions in total). They noted that small hospitals had a higher AKI mortality than larger ones, although the NIS definition of small hospitals with 250 beds or less would apply to very few acute trusts in England, if any. The authors postulated that higher AKI mortality figures on weekends and in smaller hospitals were related to reduced provision of specialist services. Their findings indicate that the lack of renal specialist care in smaller hospitals is a problem that is not unique to England.
Conclusions
Our data support the NCEPOD conclusions that many patients are not receiving optimal care. Whereas mortality data at individual hospital level should be interpreted cautiously, 25 the substantial differences between large groups of trusts cannot be ignored.
More than half the acute hospital trusts in England do not have an in-house specialist renal service. Their AKI mortality is significantly higher and probably inappropriately so. Two suggestions follow:
(i) The UK Renal Registry publishes an annual nation-wide report that contains de-anonymized centre-specific measures of both process and outcome among patients on renal replacement therapy. 1 Perhaps a similar systematic approach should be extended to hospital services that treat patients with AKI. (ii) National renal services planning must consider both AKI and CKD. Whether to improve facilities in the 55% of hospitals with no specialist renal service or to organize ways of allowing patients admitted to those hospitals to access the expertise in the specialist renal units, or a combination, is beyond a scientific paper but the probability that outcomes can be improved and lives saved should drive the discussion. 
